Tom C. Thomas net worth and biography

Tom Thomas Biography and Net Worth

Insider of Vincerx Pharma
Tom Thomas is the General Counsel and Chief Legal Officer of Vincerx.  Before joining Vincerx, Mr Thomas was a partner at Pillsbury Winthrop Shaw Pittman LLP, a leading international law firm with offices in major metropolitan centers around the world.  He has over 30 years of experience representing life science and technology companies at all stages of development, from start-up and emerging companies, to pre-IPO companies, to large public and private companies.  His practice has focused on corporate and securities matters, including corporate governance, debt and equity financings, public and private acquisitions and dispositions, venture capital financings and investments, SPAC transactions, PIPE offerings, joint ventures and strategic alliances, SEC compliance and reporting, executive compensation, and technology transactions.

Mr Thomas received his BBA in Accounting from the University of Iowa, where he graduated summa cum laude, and his JD from the University of Minnesota Law School, where he graduated magna cum laude.

What is Tom C. Thomas' net worth?

The estimated net worth of Tom C. Thomas is at least $269,233.82 as of June 29th, 2021. Mr. Thomas owns 205,522 shares of Vincerx Pharma stock worth more than $269,234 as of February 5th. This net worth evaluation does not reflect any other assets that Mr. Thomas may own. Additionally, Mr. Thomas receives an annual salary of $444,140.00 as Insider at Vincerx Pharma. Learn More about Tom C. Thomas' net worth.

How old is Tom C. Thomas?

Mr. Thomas is currently 63 years old. There are 3 older executives and no younger executives at Vincerx Pharma. Learn More on Tom C. Thomas' age.

What is Tom C. Thomas' salary?

As the Insider of Vincerx Pharma, Inc., Mr. Thomas earns $444,140.00 per year. The highest earning executive at Vincerx Pharma is Dr. Ahmed M. Hamdy M.D., Founder, Chairman & CEO, who commands a salary of $614,910.00 per year. Learn More on Tom C. Thomas' salary.

How do I contact Tom C. Thomas?

The corporate mailing address for Mr. Thomas and other Vincerx Pharma executives is 260 SHERIDAN AVENUE SUITE 400, PALO ALTO CA, 94306. Vincerx Pharma can also be reached via phone at 650-800-6676. Learn More on Tom C. Thomas' contact information.

Has Tom C. Thomas been buying or selling shares of Vincerx Pharma?

Tom C. Thomas has not been actively trading shares of Vincerx Pharma during the past quarter. Most recently, on Wednesday, December 22nd, Tom C. Thomas bought 1,000 shares of Vincerx Pharma stock. The stock was acquired at an average cost of $10.23 per share, with a total value of $10,230.00. Learn More on Tom C. Thomas' trading history.

Who are Vincerx Pharma's active insiders?

Vincerx Pharma's insider roster includes Laura Bushnell (Director), Ahmed Hamdy (CEO), Raquel Izumi (Insider), Andrew McDonald (Director), Alexander Seelenberger (CFO), and Tom Thomas (Insider). Learn More on Vincerx Pharma's active insiders.

Are insiders buying or selling shares of Vincerx Pharma?

During the last year, Vincerx Pharma insiders bought shares 6 times. They purchased a total of 161,618 shares worth more than $205,515.04. The most recent insider tranaction occured on December, 14th when insider Raquel E Izumi bought 28,738 shares worth more than $25,289.44. Insiders at Vincerx Pharma own 23.6% of the company. Learn More about insider trades at Vincerx Pharma.

Information on this page was last updated on 12/14/2022.

Tom C. Thomas Insider Trading History at Vincerx Pharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2021Buy1,000$10.23$10,230.00View SEC Filing Icon  
6/29/2021Buy2,000$12.58$25,160.00205,522View SEC Filing Icon  
See Full Table

Tom C. Thomas Buying and Selling Activity at Vincerx Pharma

This chart shows Tom C Thomas's buying and selling at Vincerx Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vincerx Pharma Company Overview

Vincerx Pharma logo
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.
Read More

Today's Range

Now: $1.31
Low: $1.30
High: $1.49

50 Day Range

MA: $0.99
Low: $0.64
High: $1.51

2 Week Range

Now: $1.31
Low: $0.63
High: $7.14

Volume

88,786 shs

Average Volume

102,623 shs

Market Capitalization

$27.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48